Azithromycin News and Research

RSS

Azithromycin, also known as Zithromax, belongs to the class of medicines known as antibacterials orantibiotics. These medicines kill bacteria (small organisms that can cause infection in humans) or stopbacteria from growing. Patients with weakened immune systems, includingpeople with HIV, tend to have more frequent andmore serious bacterial infections. Azithromycinwas approved by the FDA on June 14, 1996, formany uses, including the prevention and treatmentof Mycobacterium avium complex (MAC) inpersons with advanced HIV infection. It is alsobeing investigated to see how well it works inpreventing other kinds of bacterial infections inpeople with HIV.

Thames typical of superbug-breeding rivers, says new study

The River Thames is rapidly becoming a breeding pool for antibiotic-resistant bacteria, according to a new study, which underlines the urgent need to cut down the amount of antibiotics currently being discharge into the river by at least 80% to arrest this trend.

5 Sep 2019

Blocking key mineral uptake could prevent gonorrhea infection

A team of researchers may have found a way to block gonorrhea infection by blocking bacterial pathogen from using zinc, an essential mineral found in many food sources.

6 Aug 2019

New measure identifies patterns of pediatric antibiotic use around the world

A new measure has identified for the first time whether the most suitable antibiotics are being used to treat newborns and children in hospital on a national basis.

16 Jun 2019

IVI and MCRI to coordinate global push for developing vaccine against Strep A bacteria

The International Vaccine Institute and Australia's Murdoch Children's Research Institute will coordinate a global push to free the world of Group A Streptococcus, the contagious bacteria that kills half a million people every year and is developing resistance to antibiotics.

31 May 2019

UIC to lead $14.6 million, multi-center COPD research project

The University of Illinois at Chicago will lead a $14.6 million, multi-center research project to determine which of two drugs -- azithromycin, an antibiotic, or roflumilast, an anti-inflammatory medication -- is the most effective at treating chronic obstructive pulmonary disease, which is also known as COPD.

10 May 2019

Combination of antibiotics prevents cancer cells from motoring

Scientists in Salford, UK have found a way to make cancer stem cells reproduce defectively "like cars without engines".

9 May 2019

Gonorrhea cases on the rise in EU/EEA countries

Following a decline in notification rates in 2016, the number of gonorrhea cases has gone up by 17% across the reporting EU/EEA countries with more than 89 000 confirmed diagnoses in 2017 - more than 240 cases a day.

25 Apr 2019

Outpatient healthcare providers inappropriately prescribe antibiotics to 40% of patients

Outpatient healthcare providers inappropriately prescribed antibiotics to 40 percent of patients in a major Veterans Affairs healthcare system, a higher figure than in previous studies examining outpatient antibiotic use, according to a new study appearing in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology published by Elsevier.

17 Apr 2019

Antibiotic levels in water and potential risk of drug-resistant bugs

A JRC report brings together data on antibiotic levels in water, showing that small concentrations have found their way into a range of Europe's waterbodies.

27 Mar 2019

Antibiotics can effectively target and eliminate senescent cells

ANTIBIOTICS have emerged as potentially lifespan-enhancing drugs, according to the results of new research carried out in the UK.

28 Nov 2018

Oral antibiotic shows promise to cure uncomplicated gonorrhea

An investigational oral antibiotic called zoliflodacin was well-tolerated and successfully cured most cases of uncomplicated gonorrhea when tested in a Phase 2 multicenter clinical trial, according to findings published today in the New England Journal of Medicine.

8 Nov 2018

New Euro-GASP program monitors continued effectiveness of treatment regimen for gonorrhea

Neisseria gonorrhoea continues to show high levels of resistance to azithromycin across the European Union and European Economic Area, according to the 2016 results of the European Gonococcal Antimicrobial Surveillance Programme.

31 Aug 2018

New report highlights continuing threat of antimicrobial resistance by dangerous bacteria

Carbapenemase-producing Enterobacteriaceae (also known as CPE) and Neisseria gonorrhoeae continue to be the most commonly reported organisms with critical resistances to antimicrobials across Australia, according to a national report released today.

22 Aug 2018

QUT researcher highlights growing impact of non-prescription antibiotics supply in pharmacies

With increased use of antibiotics worldwide linked to growing antibiotic resistance, a world-first study co-authored by a QUT researcher has highlighted the growing impact of non-prescription supply of antibiotics in community pharmacies, and the urgent need for better enforcement of laws.

20 Jul 2018

Blood telomeres can help predict risk of disease worsening or death in COPD patients

Some patients with COPD demonstrate signs of accelerated aging. In a new study published in the journal CHEST researchers report that measuring blood telomeres, a marker of aging of cells, can be used to predict future risk of the disease worsening or death.

12 Jul 2018

ECDC whole genome sequencing study helps understand prevalence of drug-resistant gonorrhea

Can whole genome sequencing illustrate changes in drug susceptibility of gonorrhoea to antimicrobials used for treatment and so help to define more effective treatment regimens? The first study of this kind within an international surveillance programme for sexually transmitted infections shows distribution of drug-resistant gonorrhoea strains across Europe.

17 May 2018

SpeeDx signs distribution agreement with Serosep to strengthen sales in the UK and Ireland

SpeeDx has announced a distribution agreement with Serosep Ltd, a leading manufacturer and distributor of laboratory diagnostic solutions. This will strengthen sales channels in the UK and Ireland, ensuring greater access to SpeeDx’s multiplexed PlexPCR and ResistancePlus molecular diagnostic tests across the region.

24 Apr 2018

Bacterial 'gene swapping' affects emergence and spread of infectious diseases

A new study by scientists at the University of Liverpool documents, for the first time, how the ability of bacteria to swap genetic material with each other can directly affect the emergence and spread of globally important infectious diseases.

17 Apr 2018

Super-gonorrhea bug infects UK man

A man from United Kingdom has acquired a gonorrhea infection with bacteria that is resistant to most antibiotics used commonly against it. The man has a regular sexual partner but picked up this superbug from a sexual encounter with a partner in south-east Asia earlier this year.

29 Mar 2018

Inappropriate antibiotic prescribing linked to patient's age and race, study shows

A patient's age and race are associated with risk of receiving an unneeded antibiotic prescription for upper respiratory conditions caused by viruses, according to a study published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

30 Jan 2018